| 000 | 01415 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517130337.0 | ||
| 264 | 0 | _c20180105 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1751-4266 | ||
| 024 | 7 |
_a10.1097/SPC.0000000000000251 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Lisa M | |
| 245 | 0 | 0 |
_aCognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients. _h[electronic resource] |
| 260 |
_bCurrent opinion in supportive and palliative care _c03 2017 |
||
| 300 |
_a38-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCognitive Dysfunction _xchemically induced |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHormone Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xadverse effects |
| 700 | 1 | _aAmidi, Ali | |
| 773 | 0 |
_tCurrent opinion in supportive and palliative care _gvol. 11 _gno. 1 _gp. 38-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/SPC.0000000000000251 _zAvailable from publisher's website |
| 999 |
_c26674121 _d26674121 |
||